arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

OPKO HEALTH, INC.

OPK
$1.38 ▲ +0.05 (+3.77%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
68 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Poor
Bearish
auto_awesome

Analytical Summary

OPKO HEALTH, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.0B
Dividend Yield
Revenue Growth 4.3%
Op. Margin -4.3%
ROIC -0.4%
FCF / Share $-0.06
Trailing P/E
Price / Book 0.9x
FCF Yield
Debt / Equity 0.29
info Valuation on last close. End-of-day price, Aug 7, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$163.58M
↑ +4.3%
Net Income Profit after all expenses
$-8.42M
↑ +94.3%
Operating Margin Operating profit as % of sales
-4.3%
↑ +89.6% 10th
FCF / Share Free cash flow per share
$-0.06
↓ -126.3%
Long-Term Debt Long-term obligations
$349.05M
↑ +1.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
8
Returns
29
Financial Health
66
Cash Quality
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 68 quarters